UMN Pharma completes $7.5 million Series B-2 financing round, with participation of 11 investors.

UMN Pharma Inc. raised $7.5 million in Series B-2 financing round from 11 investors including Pacific Rim Ventures, Nomura Research & Advisory, NIF SMBC Ventures, SPARX Asset Management , Japan Asia Investment, Orix Capital, Tokyo Small and Medium Business Investment & Consultation, Mizuho Securities, Mizuho Capital, Nagoya Small and Medium Business Investment & Consultation, and Resona Capital.